References
-
1) Dynamic change of MMP-9 in the diabetic stroke visualized by optical imaging and treated with CD28 superagonist.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: BIOMATER SCI-UKImpactFactor: 5.8DOI: 10.1039/d0bm02014aPMID: 33585848 -
2) Design, synthesis and biological evaluation of N-anthraniloyl tryptamine derivatives as pleiotropic molecules for the therapy of malignant glioma.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: EUR J MED CHEMImpactFactor: 6DOI: 10.1016/j.ejmech.2021.113564PMID: 34091208 -
3) CircFBXL5 promotes the 5-FU resistance of breast cancer via modulating miR-216b/HMGA2 axis.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: CANCER CELL INTImpactFactor: 5.8DOI: 10.1186/s12935-021-02088-3PMID: 34281530 -
4) Phenylethanoid Glycosides From Callicarpa kwangtungensis Chun Attenuate TNF-α-Induced Cell Damage by Inhibiting NF-κB Pathway and Enhancing Nrf2 Pathway in A549 Cells.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: FRONT PHARMACOLImpactFactor: 5.6DOI: 10.3389/fphar.2021.693983PMID: 34305604 -
5) Sirt1 inhibits kidney stones formation by attenuating calcium oxalate-induced cell injury.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: CHEM-BIOL INTERACTImpactFactor: 4.7DOI: 10.1016/j.cbi.2021.109605PMID: 34333021 -
6) REV-ERBα agonist SR9009 suppresses IL-1β production in macrophages through BMAL1-dependent inhibition of inflammasome.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: BIOCHEM PHARMACOLImpactFactor: 5.3DOI: 10.1016/j.bcp.2021.114701PMID: 34324866 -
7) Potential protein–phenotype correlation in three lipopolysaccharide-responsive beige-like anchor protein-deficient patients.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: WORLD J CLIN CASESImpactFactor: 1DOI: 10.12998/wjcc.v9.i21.5873PMID: 34368306 -
8) miR‑29b suppresses proliferation and induces apoptosis of hepatocellular carcinoma ascites H22 cells via regulating TGF‑β1 and p53 signaling pathway.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: INT J MOL MEDImpactFactor: 5.7DOI: 10.3892/ijmm.2021.4990PMID: 34184070 -
9) Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: J ETHNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.jep.2021.114350PMID: 34157326 -
10) Moderate endurance training reduced hepatic tumourigenesis associated with lower lactate overload compared to high‐intensity interval training.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: CLIN EXP PHARMACOL PImpactFactor: 2.9DOI: 10.1111/1440-1681.13536PMID: 34096088 -
11) Long non-coding RNA ELFN1-AS1 in the pathogenesis of pancreatic cancer.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: ANN TRANSL MEDDOI: 10.21037/atm-21-2376PMID: 34164511 -
12) Low-molecular-weight heparin calcium attenuates the tourniquet-induced ischemia-reperfusion injury in rats.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: BRAIN INJURYImpactFactor: 1.5DOI: 10.1016/j.injury.2021.03.006PMID: 33726921 -
13) Activation of RSK2 upregulates SOX8 to promote methotrexate resistance in gestational trophoblastic neoplasia.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: LAB INVESTImpactFactor: 5.1DOI: 10.1038/s41374-021-00651-0PMID: 34373588 -
14) Ginseng–Astragalus–oxymatrine injection ameliorates cyclophosphamide-induced immunosuppression in mice and enhances the immune activity of RAW264. 7 cells.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: J ETHNOPHARMACOLImpactFactor: 4.8DOI: 10.1016/j.jep.2021.114387PMID: 34216728 -
15) Yes associated protein 1 promotes resistance to 5-fluorouracil in gastric cancer by regulating GLUT3-dependent glycometabolism reprogramming of tumor-associated macrophages.
Product: beta Actin Antibody (#AF7018)Year: 2021Journal: ARCH BIOCHEM BIOPHYSImpactFactor: 3.8DOI: 10.1016/j.abb.2021.108838PMID: 33727040